Pieter Zanen

Pieter Zanen

Auto-generated profile, based on publicly available information

Pieter Zanen

Department of Pulmonology, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2015 in Nature
Verified
Journal Article
Closed access
PDF file
ALAdam E Locke
Adam E Locke
BKBratati Kahali
Bratati Kahali
SBSonja I Berndt
Sonja I Berndt
AJAnne E Justice
Anne E Justice
TPTune H Pers
Tune H Pers
ESElizabeth K. Speliotes
Elizabeth K. Speliotes

5 October 2014 in Nature Genetics
Verified
Journal Article
Open access
PDF file
TCThe Electronic Medical Records and Genomics (eMERGE) Consortium
The Electronic Medical Records and Genomics (eMERGE) Consortium
AWAndrew R Wood
Andrew R Wood
TCThe MIGen Consortium
The MIGen Consortium
TCThe PAGE Consortium
The PAGE Consortium
TSThe LifeLines Cohort Study
The LifeLines Cohort Study
TFTimothy M Frayling
Timothy M Frayling
Timothy Frayling, Joel Hirschhorn, Peter Visscher and colleagues report a meta-analysis of genome-wide association studies for adult height in 253,288 individuals. They identify 697 variants in 423 loci significantly associated with adult height and find that these variants cluster in pathways involved in growth and together explain one-fifth of the heritability for this trait. Using genome-wide data from 253,288 individuals, we identified 697 variants at genome-wide significance that together explained one-fifth of the heritability for adult height. By testing different numbers of variants in independent studies, we show that the most strongly associated ∼2,000, ∼3,700 and ∼9,500 SNPs explained ∼21%, ∼24% and ∼29% of phenotypic variance. Furthermore, all common variants together captured 60% of heritability. The 697 variants clustered in 423 loci were enriched for genes, pathways and tissue types known to be involved in growth and together implicated genes and pathways not highlighted in earlier efforts, such as signaling by fibroblast growth factors, WNT/β-catenin and chondroitin sulfate–related genes. We identified several genes and pathways not previously connected with human skeletal growth, including mTOR, osteoglycin and binding of hyaluronic acid. Our results indicate a genetic architecture for human height that is characterized by a very large but finite number (thousands) of causal variants.

6 February 2017 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CICOPDGene Investigators
COPDGene Investigators
BHBrian D Hobbs
Brian D Hobbs
EIECLIPSE Investigators
ECLIPSE Investigators
LILifeLines Investigators
LifeLines Investigators
SGSPIROMICS Research Group
SPIROMICS Research Group
MCMichael H Cho
Michael H Cho

1 September 2013 in Chest
Verified
Journal Article
Closed access
PDF file
AVAdriane D. M. Vorselaars
Adriane D. M. Vorselaars
WWWim A. Wuyts
Wim A. Wuyts
VVVeronique M. M. Vorselaars
Veronique M. M. Vorselaars
PZPieter Zanen
Pieter Zanen
VDVera H. M. Deneer
Vera H. M. Deneer
JGJan C. Grutters
Jan C. Grutters

1 October 2012 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
JWJemma B. Wilk
Jemma B. Wilk
NSNick R. G. Shrine
Nick R. G. Shrine
LLLaura R. Loehr
Laura R. Loehr
JZJing Hua Zhao
Jing Hua Zhao
AMAni Manichaikul
Ani Manichaikul
BSBruno H. Stricker
Bruno H. Stricker
Rationale: Genome-wide association studies (GWAS) have identified loci influencing lung function, but fewer genes influencing chronic obstructive pulmonary disease (COPD) are known. Objectives: Perform meta-analyses of GWAS for airflow obstruction, a key pathophysiologic characteristic of COPD assessed by spirometry, in population-based cohorts examining all participants, ever smokers, never smokers, asthma-free participants, and more severe cases. Methods: Fifteen cohorts were studied for discovery (3,368 affected; 29,507 unaffected), and a population-based family study and a meta-analysis of case-control studies were used for replication and regional follow-up (3,837 cases; 4,479 control subjects). Airflow obstruction was defined as FEV1 and its ratio to FVC (FEV1/FVC) both less than their respective lower limits of normal as determined by published reference equations. Measurements and Main Results: The discovery meta-analyses identified one region on chromosome 15q25.1 meeting genome-wide significance in ever smokers that includes AGPHD1, IREB2, and CHRNA5/CHRNA3 genes. The region was also modestly associated among never smokers. Gene expression studies confirmed the presence of CHRNA5/3 in lung, airway smooth muscle, and bronchial epithelial cells. A single-nucleotide polymorphism in HTR4, a gene previously related to FEV1/FVC, achieved genome-wide statistical significance in combined meta-analysis. Top single-nucleotide polymorphisms in ADAM19, RARB, PPAP2B, and ADAMTS19 were nominally replicated in the COPD meta-analysis. Conclusions: These results suggest an important role for the CHRNA5/3 region as a genetic risk factor for airflow obstruction that may be independent of smoking and implicate the HTR4 gene in the etiology of airflow obstruction.

7 April 2011 in Thorax
Verified
Journal Article
Closed access
PDF file
Firdaus Mohamed HoeseinFirdaus Mohamed Hoesein
Firdaus Mohamed Hoesein
BHBartjan de Hoop
Bartjan de Hoop
PZPieter Zanen
Pieter Zanen
HGHester Gietema
Hester Gietema
CKC. L. J. J. Kruitwagen
C. L. J. J. Kruitwagen
JLJan-Willem J Lammers
Jan-Willem J Lammers
Background Emphysema and small airway disease both contribute to chronic obstructive pulmonary disease (COPD), a disease characterised by accelerated decline in lung function. The association between the extent of emphysema in male current and former smokers and lung function decline was investigated. Methods Current and former heavy smokers participating in a lung cancer screening trial were recruited to the study and all underwent CT. Spirometry was performed at baseline and at 3-year follow-up. The 15th percentile (Perc15) was used to assess the severity of emphysema. Results 2085 men of mean age 59.8 years participated in the study. Mean (SD) baseline Perc15 was −934.9 (19.5) HU. A lower Perc15 value correlated with a lower forced expiratory volume in 1 s (FEV1) at baseline (r=0.12, p<0.001). Linear mixed model analysis showed that a lower Perc15 was significantly related to a greater decline in FEV1 after follow-up (p<0.001). Participants without baseline airway obstruction who developed it after follow-up had significantly lower mean (SD) Perc15 values at baseline than those who did not develop obstruction (−934.2 (17.1) HU vs −930.2 (19.7) HU, p<0.001). Conclusion Greater baseline severity of CT-detected emphysema is related to lower baseline lung function and greater rates of lung function decline, even in those without airway obstruction. CT-detected emphysema aids in identifying non-obstructed male smokers who will develop airflow obstruction.